FYK 1258
Latest Information Update: 25 Mar 2008
At a glance
- Originator Daiichi Fine Chemical
- Class
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 25 Mar 2008 Discontinued - Preclinical for Pain in Japan (unspecified route)
- 18 Dec 2003 No development reported - Preclinical for Pain in Japan (unspecified route)
- 30 Mar 2001 New profile